Help oversee talent in skills competition

Sign up to be a workshop supervisor at WorldSkills London 2011

WorldSkills London 2011 is recruiting manufacturing professionals from across the country to oversee the best young talent at the largest skills competition in the world.

Bringing together 1,000 young people from across the globe, the event see will the youngsters compete for medals in 45 categories across six sectors, including manufacturing (and engineering) technology, construction and building technology and transportation and logistics.

WorldSkills London 2011 takes place from 5-8 October at ExCeL London and manufacturing professionals are needed to help as workshop supervisors, who will be responsible for the preparation of materials, health and safety, security and workshop upkeep. They will also support the international judging panel as they test the competitors.

Signing up for the job requires a commitment of approximately one day per month for the next year, increasing to two or three days a month in the six months leading up to the competition and full-time for 10-12 days during the competition. Accommodation, expenses and a remuneration package are available to those who sign up.

Executive director of WorldSkills London 2011, Aidan Jones said: ‘Skills shape our world and workshop supervisors will play an essential role in this massive demonstration of the next generation of talent.’

You may also like

Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Finance

GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib — currently under FDA review for potential 2026 approval in non-small cell lung cancer
Finance

UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and prolonged deal timelines
You need to be a subscriber to read this article.
Click here to find out more.
Finance

ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic platforms
Finance

Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and other complex injectable therapies to vaccines and emergency room medications
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Finance

T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both technologies in-house
Subscribe now